Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06741241 · ClinicalTrials.gov registry record · NA
Effectiveness of an EHealth Intervention for Uptake of Cervical Cancer Screening in Hispanic Women
A NA study, sponsored by Florida A&M University.
- Not yet
- Registry status
- NA
- Development phase
- 170
- Enrollment target
NCT06741241: Clinical Trial NA study, sponsored by Florida A&M University.
NCT06741241 is a NA study that has not yet begun recruiting, run by Florida A&M University. The registered enrollment target is 170 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06741241, a NA study, has not yet begun recruiting, sponsored by Florida A&M University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
Study Summary
This study will test the effectiveness of an eHealth promotora (lay health advisor) outreach strategy to increase cervical cancer screening in Hispanic women. The investigators will recruit 160 Hispanic women ages 21-65 who are not up to date with cervical cancer screening or have never been screened, with the goal to evaluate screening knowledge, behavior, and intervention effects on cervical cancer screening outcomes. The study will utilize a two-arm, cluster randomized trial design, and participants will be randomly assigned to the cervical cancer education intervention or a nutrition education control group. The cervical cancer education arm will utilize a promotora to deliver an educational session virtually to encourage cervical cancer screening and receive a resource list for screening sites. The control group will participate in an educational session virtually about the importance of healthy nutrition. The primary study outcome is receipt of cervical cancer screening measured six months following receiving the intervention. The secondary outcomes will include cervical cancer screening knowledge and self-efficacy (confidence to receive cervical cancer screening). The research objective is to test the eHealth promotora intervention effectiveness for promoting cervical cancer screening in an under-screened Hispanic population.
Primary Outcome
Proportion of participants who complete cervical cancer screening determined by cervical cancer screening measure which asks about the last Pap test completed confirmed by chart review if possible.
Interventions
- BEHAVIORAL eHealth Promotora
- BEHAVIORAL eHealth Healthy Nutrition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2029-09 |
| Phase | NA |
What is known before NCT06741241 opens enrollment
NCT06741241 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which eHealth Promotora is the first listed.
NCT06741241 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06741241 about?
NCT06741241 is a clinical study titled "Effectiveness of an EHealth Intervention for Uptake of Cervical Cancer Screening in Hispanic Women". This study will test the effectiveness of an eHealth promotora (lay health advisor) outreach strategy to increase cervical cancer screening in Hispanic women. The investigators will recruit 160 Hispanic women ages 21-65 who are not up to date with cervical cancer screening or have never been screene...
What is the current status of trial NCT06741241?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 170 participants. The study started on 2026-07-01. Estimated completion is 2029-09.
What interventions are being tested in trial NCT06741241?
The interventions under investigation include: eHealth Promotora (BEHAVIORAL), eHealth Healthy Nutrition (BEHAVIORAL).
Who is sponsoring clinical trial NCT06741241?
This trial is sponsored by Florida A&M University, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06741241's enrollment target sits among peer trials
170 614th of 2000 higher than 1,382 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI